Serum Institute of India

COVID: Govt Panel Recommends Phase 3 Trial of Covovax as Booster for Adults

10 Billion COVID-19 Vaccine Doses Later, What’s India’s Contribution?

Centre’s Expert Panel Recommends Regular Market Approval for Covishield, Covaxin

How Will Booster Doses, Shots for Minors Change India’s Vaccine Supply Calculus?

COVID-19: Govt Panel Recommends EUA for Covovax, Corbevax and Molnupiravir

UK Study Makes Case for AstraZeneca Boosters

WHO Okays ‘Emergency Use’ Listing for Serum Institute-Novavax COVID Vaccine